Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023

BUY
$37.32 - $49.29 $0 - $0
0 New
0 $0
Q1 2023

May 01, 2023

BUY
$37.58 - $52.57 $9,395 - $13,142
250 Added 25.0%
1,250 $50,000
Q3 2022

Nov 09, 2022

SELL
$53.86 - $66.8 $377,774 - $468,535
-7,014 Reduced 87.52%
1,000 $54,000
Q2 2022

Aug 11, 2022

SELL
$63.83 - $80.0 $156,383 - $196,000
-2,450 Reduced 23.41%
8,014 $515,000
Q4 2021

Feb 09, 2022

BUY
$74.57 - $87.19 $123,040 - $143,863
1,650 Added 18.72%
10,464 $899,000
Q3 2021

Oct 28, 2021

SELL
$73.77 - $83.61 $290,727 - $329,507
-3,941 Reduced 30.9%
8,814 $707,000
Q2 2021

Jul 15, 2021

BUY
$80.5 - $88.01 $466,175 - $509,665
5,791 Added 83.16%
12,755 $1.03 Million
Q1 2021

Apr 23, 2021

BUY
$76.38 - $86.03 $531,910 - $599,112
6,964 New
6,964 $587,000
Q4 2020

Feb 09, 2021

SELL
$75.39 - $82.36 $397,305 - $434,037
-5,270 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$78.33 - $90.73 $65,013 - $75,305
-830 Reduced 13.61%
5,270 $424,000
Q2 2020

Aug 14, 2020

BUY
$78.66 - $94.14 $2,831 - $3,389
36 Added 0.59%
6,100 $525,000
Q1 2020

May 13, 2020

BUY
$71.57 - $93.3 $365,006 - $475,830
5,100 Added 529.05%
6,064 $493,000
Q4 2018

Feb 13, 2019

BUY
$61.45 - $77.8 $59,237 - $74,999
964 New
964 $63,000
Q2 2018

Aug 10, 2018

SELL
$63.43 - $75.41 $64,635 - $76,842
-1,019 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$62.56 - $72.26 $25,587 - $29,554
-409 Reduced 28.64%
1,019 $66,000
Q4 2017

Feb 13, 2018

BUY
$61.45 - $66.05 $87,750 - $94,319
1,428 New
1,428 $92,000
Q3 2017

Nov 14, 2017

SELL
$59.5 - $64.61 $65,450 - $71,071
-1,100 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
1,100
1,100 $67,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.